• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉注射后普罗帕酮在大鼠体内的组织分布。

Tissue distribution of propafenone in the rat after intravenous administration.

作者信息

Fernández J, Lligoña L, Puigdemont A, Guitart R, Riu J L, Arboix M

机构信息

Department of Pharmacology, Veterinary Faculty, Universitat Autònoma de Barcelona, Spain.

出版信息

Eur J Drug Metab Pharmacokinet. 1991 Jan-Mar;16(1):23-7. doi: 10.1007/BF03189870.

DOI:10.1007/BF03189870
PMID:1936057
Abstract

Tissue distribution of propafenone has been studied in the rat. Measurement of propafenone was made in several tissues: plasma, heart, kidney, lung, liver, muscle, fat and brain, after i.v. administration of 2 mg/kg of the drug. The plasma propafenone kinetics profile can be described by a two-compartmental model. The pharmacokinetic parameters, derived from plasma levels, showed a t1/2 beta of 55.4 min, the central Vd/kg of 2.4 ml/kg, the Cl of 62.8 ml/min.kg and the AUC0-oo of 31.6 micrograms.min/ml. The analysis of the propafenone tissue distribution showed the highest concentration of drug in the lung, followed by the heart and kidneys. A significant concentration was found in brain, muscle and adipose tissue, with concentration ratios (tissue/plasma) above 1. The half-life values obtained for individual organs and tissues are similar to those obtained in plasma, around 1 h. In the post-distributive phase, plasma and tissue concentrations decline in parallel.

摘要

已在大鼠中研究了普罗帕酮的组织分布。静脉注射2mg/kg药物后,在几个组织中测定了普罗帕酮:血浆、心脏、肾脏、肺、肝脏、肌肉、脂肪和脑。血浆普罗帕酮动力学曲线可用二室模型描述。从血浆水平得出的药代动力学参数显示,β半衰期为55.4分钟,中央分布容积为2.4ml/kg,清除率为62.8ml/min.kg,AUC0-∞为31.6μg.min/ml。普罗帕酮组织分布分析显示,肺中药物浓度最高,其次是心脏和肾脏。在脑、肌肉和脂肪组织中发现有显著浓度,浓度比(组织/血浆)大于1。各个器官和组织获得的半衰期值与血浆中获得的值相似,约为1小时。在分布后阶段,血浆和组织浓度平行下降。

相似文献

1
Tissue distribution of propafenone in the rat after intravenous administration.静脉注射后普罗帕酮在大鼠体内的组织分布。
Eur J Drug Metab Pharmacokinet. 1991 Jan-Mar;16(1):23-7. doi: 10.1007/BF03189870.
2
Propafenone kinetics in the horse. Comparative analysis of compartmental and noncompartmental models.马体内普罗帕酮的动力学。房室模型与非房室模型的比较分析。
J Pharmacol Methods. 1990 Apr;23(2):79-85. doi: 10.1016/0160-5402(90)90035-j.
3
Comparison of pharmacokinetics of M1, M2, M3, and M4 after intravenous administration of DA-125 or ME2303 to mice and rats. New adriamycin analogues containing fluorine.给小鼠和大鼠静脉注射DA - 125或ME2303后M1、M2、M3和M4的药代动力学比较。含氟的新型阿霉素类似物。
Biopharm Drug Dispos. 1996 Jul;17(5):373-420. doi: 10.1002/(SICI)1099-081X(199607)17:5<373::AID-BDD373>3.0.CO;2-U.
4
Pharmacokinetics of fosfomycin in chickens after a single intravenous dose and tissue levels following chronic oral administration.单剂量静脉注射后磷霉素在鸡体内的药代动力学及长期口服给药后的组织水平
Vet Res. 1997 Nov-Dec;28(6):581-8.
5
Plasma pharmacokinetics and tissue distribution in CD2F1 mice of Pc4 (NSC 676418), a silicone phthalocyanine photodynamic sensitizing agent.硅酞菁光动力敏化剂Pc4(NSC 676418)在CD2F1小鼠体内的血浆药代动力学和组织分布
Cancer Chemother Pharmacol. 1999;44(4):283-94. doi: 10.1007/s002800050979.
6
Hemodialysis removal of propafenone.血液透析清除普罗帕酮。
Pharmacotherapy. 1989;9(5):331-3. doi: 10.1002/j.1875-9114.1989.tb04145.x.
7
Pharmacokinetics of intravenous propafenone in patients with episodes of paroxysmal supraventricular tachycardia.静脉注射普罗帕酮在阵发性室上性心动过速发作患者中的药代动力学
Methods Find Exp Clin Pharmacol. 1985 Aug;7(8):435-8.
8
Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) in CD2F1 mice1.17-(烯丙基氨基)-17-去甲氧基格尔德霉素(NSC 330507)在CD2F1小鼠体内的血浆药代动力学及组织分布1
Cancer Chemother Pharmacol. 2001 Apr;47(4):291-302. doi: 10.1007/s002800000242.
9
Comparative pharmacokinetics between a microdose and therapeutic dose for clarithromycin, sumatriptan, propafenone, paracetamol (acetaminophen), and phenobarbital in human volunteers.在人类志愿者中比较克拉霉素、舒马曲坦、普罗帕酮、对乙酰氨基酚(扑热息痛)和苯巴比妥的微剂量与治疗剂量的药代动力学。
Eur J Pharm Sci. 2011 Jun 14;43(3):141-50. doi: 10.1016/j.ejps.2011.04.009. Epub 2011 Apr 20.
10
[Studies on the pharmacokinetics of hexobendine in rats. I. Distribution following i.v. administration (author's transl)].己酮可可碱在大鼠体内的药代动力学研究。I. 静脉注射后的分布(作者译)
Arzneimittelforschung. 1975 Sep;25(9):1414-7.

引用本文的文献

1
A Tissue Distribution Study of Propafenone in an Intentional Fatal Poisoning Case.在一个故意中毒致死案例中普罗帕酮的组织分布研究。
Int J Mol Sci. 2024 May 10;25(10):5202. doi: 10.3390/ijms25105202.

本文引用的文献

1
[Studies on the analysis of propafenone by means of internal analogue standardization (author's transl)].
Arzneimittelforschung. 1982;32(1):1-6.
2
Suppression of ventricular arrhythmias by propafenone, a new antiarrhythmic agent, during acute myocardial infarction in the conscious dog. A comparative study with lidocaine.新型抗心律失常药物普罗帕酮对清醒犬急性心肌梗死期间室性心律失常的抑制作用。与利多卡因的比较研究。
Circulation. 1982 Dec;66(6):1190-8. doi: 10.1161/01.cir.66.6.1190.
3
High-performance liquid chromatographic analysis of propafenone in human plasma samples.
J Chromatogr. 1982 Jul 9;230(2):448-53. doi: 10.1016/s0378-4347(00)80498-3.
4
Propafenone--a new antiarrhythmic drug.普罗帕酮——一种新型抗心律失常药物。
Eur Heart J. 1980 Aug;1(4):309-13. doi: 10.1093/oxfordjournals.eurheartj.a061135.
5
Clinical pharmacology of propafenone.普罗帕酮的临床药理学。
Circulation. 1983 Sep;68(3):589-96. doi: 10.1161/01.cir.68.3.589.
6
Propafenone disposition kinetics in cardiac arrhythmia.
Clin Pharmacol Ther. 1984 Aug;36(2):163-8. doi: 10.1038/clpt.1984.157.
7
The metabolic fate of 2H-labelled propafenone in man.人体内2H标记普罗帕酮的代谢转归
Eur J Drug Metab Pharmacokinet. 1984 Jan-Mar;9(1):41-55. doi: 10.1007/BF03189604.
8
Investigations on the pharmacokinetics of propafenone in man.
Arzneimittelforschung. 1983;33(5):763-70.
9
A controlled trial of propafenone for treatment of frequent and repetitive ventricular premature complexes.
Am J Cardiol. 1984 Jan 1;53(1):77-83. doi: 10.1016/0002-9149(84)90687-8.
10
Pharmacokinetics of intravenous propafenone in patients with episodes of paroxysmal supraventricular tachycardia.静脉注射普罗帕酮在阵发性室上性心动过速发作患者中的药代动力学
Methods Find Exp Clin Pharmacol. 1985 Aug;7(8):435-8.